216 related articles for article (PubMed ID: 24755224)
1. Two p90 ribosomal S6 kinase isoforms are involved in the regulation of mitotic and meiotic arrest in Artemia.
Duan RB; Zhang L; Chen DF; Yang F; Yang JS; Yang WJ
J Biol Chem; 2014 Jun; 289(23):16006-15. PubMed ID: 24755224
[TBL] [Abstract][Full Text] [Related]
2. Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.
Li R; Chen DF; Zhou R; Jia SN; Yang JS; Clegg JS; Yang WJ
J Biol Chem; 2012 May; 287(19):15923-34. PubMed ID: 22427657
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p90 ribosomal S6 kinase in termination of cell cycle arrest during development of Artemia-encysted embryos.
Dai JQ; Zhu XJ; Liu FQ; Xiang JH; Nagasawa H; Yang WJ
J Biol Chem; 2008 Jan; 283(3):1705-1712. PubMed ID: 17999958
[TBL] [Abstract][Full Text] [Related]
5. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.
Smith JA; Poteet-Smith CE; Malarkey K; Sturgill TW
J Biol Chem; 1999 Jan; 274(5):2893-8. PubMed ID: 9915826
[TBL] [Abstract][Full Text] [Related]
6. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs.
Bhatt RR; Ferrell JE
J Biol Chem; 2000 Oct; 275(42):32983-90. PubMed ID: 10934212
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of RSK1 characterizes high-grade gliomas with immune infiltration.
M Hajj GN; da Silva FF; de Bellis B; Lupinacci FCS; Bellato HM; Cruz JR; Segundo CNC; Faquini IV; Torres LC; Sanematsu PI; Begnami MD; Martins VR; Roffé M
Mol Oncol; 2020 Jan; 14(1):159-179. PubMed ID: 31701625
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
Cavet ME; Lehoux S; Berk BC
J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
[TBL] [Abstract][Full Text] [Related]
11. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
Zhao Y; Bjorbaek C; Moller DE
J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
[TBL] [Abstract][Full Text] [Related]
12. Bub1 is activated by the protein kinase p90(Rsk) during Xenopus oocyte maturation.
Schwab MS; Roberts BT; Gross SD; Tunquist BJ; Taieb FE; Lewellyn AL; Maller JL
Curr Biol; 2001 Feb; 11(3):141-50. PubMed ID: 11231148
[TBL] [Abstract][Full Text] [Related]
13. Identification of RSK substrates using an analog-sensitive kinase approach.
Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
[TBL] [Abstract][Full Text] [Related]
14. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
15. The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations.
Nam HJ; Kim S; Lee MW; Lee BS; Hara T; Saya H; Cho H; Lee JH
Cell Signal; 2008 Jul; 20(7):1349-58. PubMed ID: 18450423
[TBL] [Abstract][Full Text] [Related]
16. Regulation and function of the RSK family of protein kinases.
Romeo Y; Zhang X; Roux PP
Biochem J; 2012 Jan; 441(2):553-69. PubMed ID: 22187936
[TBL] [Abstract][Full Text] [Related]
17. Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
Stratford AL; Reipas K; Hu K; Fotovati A; Brough R; Frankum J; Takhar M; Watson P; Ashworth A; Lord CJ; Lasham A; Print CG; Dunn SE
Stem Cells; 2012 Jul; 30(7):1338-48. PubMed ID: 22674792
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Implications of RSK1-3 in Human Breast Cancer.
Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
[TBL] [Abstract][Full Text] [Related]
19. Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication.
Kuang E; Tang Q; Maul GG; Zhu F
J Virol; 2008 Feb; 82(4):1838-50. PubMed ID: 18057234
[TBL] [Abstract][Full Text] [Related]
20. p90 ribosomal S6 kinase 1 (RSK1) isoenzyme specifically regulates cytokinesis progression.
Nam HJ; Lee IJ; Jang S; Bae CD; Kwak SJ; Lee JH
Cell Signal; 2014 Feb; 26(2):208-19. PubMed ID: 24269382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
